Table 2 Outcomes of patients assessed at hospital in the video- and telephone triage group respectively, within 8, 24 and 48 h after the call

0–8 HOURS AFTER THE CALL

Patients assessed at hospital, n (%)

175 (47.2%)

173 (45.2%)

0.58*

Hospital outcome, n (%)

0.003^#

No paraclinical testing/treatment/hospitalization

113 (64.6%)

140 (80.9%)

1.0 (ref.)

Received paraclinical testing/treatment and/or hospitalized < 12 h

48 (27.4%)

26 (15.0%)

2.29 (1.34–3.92)

Hospitalized ≥ 12 h

Hospitalized ≥ 12 h

14 (8.0%)

7 (4.1%)

2.48 (0.97–6.35)

Received paraclinical testing

41 (23.6%)

48 (27.8%)

0.37*

Received treatment

55 (31.6%)

29 (16.8%)

0.001*

Received prescription

35 (20.1%)

50 (28.9%)

0.06*

Median temperature, °C (IQR) (n)

38.5 (37.7–39.2) (120)

38.4 (37.6–39.3) (81)

0.8^¤

0–24 HOURS AFTER THE CALL

Total number of patients assessed at hospital, n (%)

188 (50.7%)

177 (46.2%)

0.22*

Hospital outcome, n (%)

0.003^#

No paraclinical testing/treatment/hospitalization

121 (64.7%)

143 (80.8%)

1.0 (ref.)

Received paraclinical testing/treatment and/or hospitalized < 12 h

50 (26.7%)

27 (15.3%)

2.17 (1.28–3.68)

Hospitalized ≥ 12 h

16 (8.6%)

7 (4.0%)

2.68 (1.07–6.73)

Received paraclinical testing

42 (22.3%)

50 (28.3%)

0.20*

Received treatment

59 (31.4%)

30 (17.0%)

0.012*

Received prescription

35 (18.6%)

52 (29.4%)

0.017*

Median temperature, °C (IQR) (n)

38.4 (37.7–39.2) (127)

38.5 (37.6–39.3) (82)

0.65^¤

0–48 HOURS AFTER THE CALL

Total number of patients assessed at hospital, n (%)

194 (52.3%)

187 (48.8%)

0.34*

Hospital outcome, n (%)

0.005^#

No paraclinical testing/treatment/hospitalization

128 (66.0%)

152 (81.3%)

1.0 (ref)

Received treatment/paraclinical testing and/or hospitalized < 12 h

50 (25.8%)

28 (15.0%)

2.0 (ref)

2.12 (1.26–3.56)

Hospitalized ≥ 12 h

16 (8.3%)

7 (3.7%)

2.55 (1.01–6.43)

Received paraclinical testing

44 (22.7%)

51 (27.3%)

0.27

Received treatment

59 (30.4%)

30 (16.0%)

0.001*

Received prescription

35 (18.0%)

53 (28.3%)

0.020*

Median temperature, °C (IQR) (n)

38.4 (37.7–39.2) (129)

38.5 (37.6–39.3) (88)

0.70^¤

Adverse events^

0

0

Diagnoses, n (%)

0.001^#

Upper respiratory tract infections

47 (24.2%)

60 (32.1%)

0.75 (0.38–1.49)

Obstructive laryngitis

31 (16.0%)

14 (7.4%)

2.12 (0.91–4.97)

Viral infection

24 (12.4%)

23 (12.3%)

1.0 (ref.)

Fever

14 (7.2%)

13 (7.0%)

1.03 (0.40–2.66)

Gastroenteritis

13 (6.7%)

5 (2.7%)

2.49 (0.77–8.10)

Pneumonia

13 (6.7%)

5 (2.7%)

2.30 (0.70–7.56)

Ear infection

12 (6.2%)

33 (17.7%)

0.35 (0.15–0.84)

Asthma/bronchitis

10 (5.2%)

6 (3.2%)

1.60 (0.50–5.11)

Other^$

30 (15.5%)

28 (15.0%)